Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zatloukal

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Sbornik Lekarsky|April 1, 1990
[Testing bronchogenic carcinoma cells for sensitivity to cytostatics in vitro and in cell cultures]P Zatloukal, F Fremuth, J Pazourek, et al.
Neoplasma|January 6, 2007
Interactions between smoking and other exposures associated with lung cancer risk in women: diet and physical activityA Kubík, P Zatloukal, L Tomásek, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 19, 2004
Dietary habits and lung cancer risk among non-smoking womenA K Kubík, P Zatloukal, L Tomásek, et al.
Sbornik Lekarsky|March 1, 1991
[Symptoms of diseases of the respiratory system and their importance in diagnosis. Summary and conclusions of research]Z Voslárová, V Bohut, A Bortlová, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
A case-control study of lung cancer among Czech womenA Kubík, P Zatloukal, P Boyle, et al.
Neoplasma|March 20, 2008
A case-control study of lifestyle and lung cancer associations by histological typesA Kubik, P Zatloukal, L Tomasek, et al.
Neoplasma|May 6, 2005
Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancerI Spasova, H Novotna, J Vachtenheim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II studyM E R O'Brien, A Szczesna, H Karnicka, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Clinical correlations of potential activity markers in systemic sclerosisR Becvár, J Stork, V Pesáková, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive diseaseP Zatloukal, F Cardenal, A Szczesna, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Sbornik Lekarsky|April 1, 1990
[Testing bronchogenic carcinoma cells for sensitivity to cytostatics in vitro and in cell cultures]P Zatloukal, F Fremuth, J Pazourek, et al.
Neoplasma|January 6, 2007
Interactions between smoking and other exposures associated with lung cancer risk in women: diet and physical activityA Kubík, P Zatloukal, L Tomásek, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 19, 2004
Dietary habits and lung cancer risk among non-smoking womenA K Kubík, P Zatloukal, L Tomásek, et al.
Sbornik Lekarsky|March 1, 1991
[Symptoms of diseases of the respiratory system and their importance in diagnosis. Summary and conclusions of research]Z Voslárová, V Bohut, A Bortlová, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
A case-control study of lung cancer among Czech womenA Kubík, P Zatloukal, P Boyle, et al.
Neoplasma|March 20, 2008
A case-control study of lifestyle and lung cancer associations by histological typesA Kubik, P Zatloukal, L Tomasek, et al.
Neoplasma|May 6, 2005
Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancerI Spasova, H Novotna, J Vachtenheim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II studyM E R O'Brien, A Szczesna, H Karnicka, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Clinical correlations of potential activity markers in systemic sclerosisR Becvár, J Stork, V Pesáková, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive diseaseP Zatloukal, F Cardenal, A Szczesna, et al.
Pageof 5